Bedrijfsvoering AbbVie Inc.

ABBV

US00287Y1091

Farmaceutische producten

Beurs gesloten - Nyse Andere beurzen 22:00:02 05-12-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
226,08 ^USD	-1,15%		-0,71%	+27,23%

03/12	AbbVie Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-03-2025 08:30 AM
02/12	AbbVie presenteert nieuwe gegevens op ASH 2025 en toont voortdurende vooruitgang in innovatieve behandelingen voor verschillende bloedkankers	CI

Uitvoerend comité: AbbVie Inc.

Bedrijfsleider

Beklede functiesVan

Robert Michael

54 jaar

Chief Executive Officer

01-07-2024

Roopal Thakkar

Chief Tech/Sci/R&D Officer

01-01-2003

Perry Siatis

General Counsel	17-10-2022
Corporate Secretary	17-10-2022

Azita Saleki-Gerhardt

61 jaar

Chief Operating Officer

01-07-2023

Scott Reents

58 jaar

Director of Finance/CFO

23-06-2022

Tim Richmond

58 jaar

Human Resources Officer

01-01-2013

Liz Shea

Investor Relations Contact

01-01-2013

Samenstelling van de raad van bestuur: AbbVie Inc.

Directeur

RadenVan

Robert Michael

54 jaar

Chairman

01-07-2025

Roxanne Austin

64 jaar

Audit Committee
Governance Committee
Compensation Committee Chair	01-01-2013
Audit Committee Chair	13-05-2021
Finance Committee	13-05-2021
Governance Committee Chair	01-12-2025
Nominating Committee Chair	01-12-2025

Edward Rapp

67 jaar

Audit Committee	01-01-2013
Governance Committee
Nominating Committee
Compensation Committee	20-08-2021
Audit Committee Chair	20-08-2021

Rebecca Roberts

72 jaar

Compensation Committee	13-02-2015
Governance Committee Chair	01-01-2011
Governance Committee
Nominating Committee

Thomas Freyman

70 jaar

Compensation Committee	08-05-2020
Audit Committee Chair	08-05-2020
Governance Committee Chair
Nominating Committee Chair

Frederick Waddell

71 jaar

Executive Committee
Compensation Committee Chair
Compensation Committee
Audit Committee Chair

Robert Alpern

74 jaar

Governance Committee	01-10-2013
Nominating Committee	01-10-2013
Compensation Committee

Brett Hart

55 jaar

Governance Committee	01-01-2016
Nominating Committee	01-01-2016
Compensation Committee Chair

Thomas Falk

66 jaar

Governance Committee Chair	02-05-2024
Nominating Committee Chair	02-05-2024
Audit Committee	09-05-2025

William Burnside

73 jaar

Executive Committee
Audit Committee	01-01-2013

Melody Meyer

67 jaar

Compensation Committee
Audit Committee	01-01-2017

Jennifer Davis

53 jaar

Governance Committee	11-10-2023
Nominating Committee	11-10-2023

Susan Quaggin

61 jaar

Director/Board Member	11-10-2023
Independent Dir/Board Member	11-10-2023

Recente benoemingen: AbbVie Inc.

12/11	LB Pharmaceuticals, Inc benoemt Kaya Pai Panandiker tot Chief Commercial Officer	CI
07/11	Adrian Bot Toegetreden tot Raad van Bestuur van Immuthera en Poltreg S.A.	CI
03/11	Vor Bio benoemt Jeremy Sokolove tot Chief Medical Officer	CI
18/10	Novo Nordisk benoemt Amerikaanse farmaveteraan te midden van toenemende prijsdruk onder Trump	RE
16/10	Galapagos NV kondigt wijzigingen in het management aan	CI
13/10	Hugel, Inc. benoemt Carrie Strom tot Global Chief Executive Officer, met ingang van 13 oktober 2025	CI
13/10	Hugel Inc. benoemt Carrie Strom tot president en CEO, met ingang van 13 oktober 2025	CI

Meer nieuws

Voormalige zaakvoerders en bestuurders: AbbVie Inc.

Insider

Beklede functies

VanTot

Richard Gonzalez

Chief Executive Officer	01-01-2013	01-07-2024
Chairman	01-01-2013	01-07-2025

Glenn Tilton

Director/Board Member	01-01-2013	01-07-2025
Independent Dir/Board Member	01-01-2013	01-07-2025

Kevin Buckbee

Comptroller/Controller/Auditor

01-03-2023

01-03-2025

Carrie Strom

Corporate Officer/Principal

08-05-2020

01-02-2025

Thomas Hudson

Chief Tech/Sci/R&D Officer	01-07-2019	10-07-2024
Corporate Officer/Principal	01-01-2016	01-07-2019

Jane Woo

Public Communications Contact

01-04-2021

01-04-2024

Katherine Rielly-Gauvin

Corporate Officer/Principal

01-01-2013

01-07-2023

Neil Gallagher

Chief Tech/Sci/R&D Officer	01-01-2020	01-04-2023
Corporate Officer/Principal	01-11-2017	01-01-2020

Frank Benenati

Public Communications Contact

01-04-2021

01-04-2023

Henry Gosebruch

Corporate Officer/Principal

01-12-2015

01-02-2023

Chris Boone

Corporate Officer/Principal

02-01-2023

Mohamed Zaki

Corporate Officer/Principal

01-09-2018

01-12-2022

Matthew Farber

Corporate Officer/Principal

01-06-2022

Michael Severino

Chief Tech/Sci/R&D Officer	01-06-2014	17-12-2018
President	17-12-2018	31-05-2022

Edward Liddy

Director/Board Member	01-01-2013	11-05-2022
Independent Dir/Board Member	01-01-2013	11-05-2022

Kate C. Liebelt

Corporate Officer/Principal

01-06-2020

30-04-2022

Todd D. Bosse

Investor Relations Contact

01-12-2021

Nataskia Lampe

Corporate Officer/Principal

01-03-2012

01-08-2021

Carlos Alban

Director/Board Member	17-12-2018	01-03-2021
Corporate Officer/Principal	01-01-2013	01-03-2021

Jose-Carlos Gutiérrez-Ramos

Corporate Officer/Principal

01-02-2020

01-01-2021

Adelle Infante

Public Communications Contact

01-12-2020

Janet Hammond

Corporate Officer/Principal

01-11-2016

01-08-2020

Vusi Moyo

Public Communications Contact

01-04-2020

Ronald O. Robison

General Counsel	14-01-2013	-
Corporate Officer/Principal	-	01-04-2020

Myra Rosario Herrle

Corporate Officer/Principal

01-08-2014

01-03-2020

Frank A. Jaeger

Sales & Marketing

01-01-2014

01-08-2019

Nadia Dac

Corporate Officer/Principal

01-12-2014

01-03-2019

Scott Brun

Corporate Officer/Principal

01-03-2019

John Westwater

Director/Board Member

01-04-2018

31-12-2018

Jim Sullivan

Private Equity Investor

01-01-2013

01-12-2018

Graig Suvannavejh

Corporate Officer/Principal

01-03-2017

01-07-2018

Melanie Gloria

Corporate Officer/Principal

01-08-2014

01-07-2018

Elizabeth Thompson

Chief Tech/Sci/R&D Officer

01-09-2015

01-05-2018

Paul Schwichtenberg

Corporate Officer/Principal

01-10-2013

01-04-2018

Gary Gordon

Corporate Officer/Principal

01-01-2013

01-04-2018

Mark Stenhouse

Corporate Officer/Principal

01-10-2016

01-03-2018

Sujay Kango

Corporate Officer/Principal

01-01-2017

01-02-2018

Shao Lee Lin

Corporate Officer/Principal

01-04-2015

01-12-2017

Thomas A. Hurwich

Comptroller/Controller/Auditor

28-02-2017

Sharon Curran

Corporate Officer/Principal

01-01-2012

01-01-2017

Francisco Velasco

Corporate Officer/Principal

01-06-2009

01-06-2016

Roy S. Roberts

Director/Board Member	01-01-2013	06-05-2016
Independent Dir/Board Member	01-01-2013	06-05-2016

Renee Tannenbaum

Corporate Officer/Principal

01-10-2012

01-01-2016

Rita Jain

Corporate Officer/Principal

01-01-2013

01-01-2016

Maria Rivas

Chief Tech/Sci/R&D Officer

01-08-2012

01-12-2015

Peter Heerma

Corporate Officer/Principal

01-12-2012

01-11-2015

David H. Donabedian

Corporate Officer/Principal

01-08-2015

Paul Wierbicki

General Counsel

01-03-2014

01-05-2015

Jennifer Mound Smoter

Public Communications Contact

01-08-2012

01-03-2015

Barry Regan

Chief Operating Officer	01-01-2013	01-03-2015
Corporate Officer/Principal	-	-

Alysa Spittle

Public Communications Contact

01-01-2013

01-01-2015

Gary Winer

Corporate Officer/Principal

01-04-2014

01-01-2015

Steven N. Gersten

Compliance Officer

01-01-2015

Mohit Rawat

Corporate Officer/Principal

01-08-2013

01-05-2014

Lily Chang

Private Equity Analyst

01-01-2013

01-01-2014

Lars Kielhorn

Corporate Officer/Principal

01-01-2011

01-01-2014

John Leonard

Chief Tech/Sci/R&D Officer

01-01-2013

01-01-2014

Donald Frail

Corporate Officer/Principal

01-01-2014

Jose Rivera

Compliance Officer

01-01-2013

01-09-2013

George Avgerinos

Corporate Officer/Principal

01-07-2008

01-07-2013

Laura Schumacher

General Counsel	01-01-2013	-
Corporate Secretary	10-02-2014	17-10-2022

Greg W. Linder

Director/Board Member

31-12-2012

Sharon Greenlees

Investor Relations Contact	01-01-2016	01-01-2018
Corporate Officer/Principal	01-01-2018	-

Björn Cochlovius

Corporate Officer/Principal

Ann Tomlin

Human Resources Officer

Gregory Miley

Public Communications Contact	-	-
General Counsel	-	-

Larry Peepo

Investor Relations Contact

William Chase

Chief Administrative Officer	19-10-2018	-
Director of Finance/CFO	-	19-10-2018

Star Seyedkazemi

Corporate Officer/Principal

David Laskow-Pooley

Director/Board Member

Paulo Vega

Corporate Officer/Principal

Kimberly Davis-Wells

Corporate Officer/Principal

Karen Hale

Compliance Officer

Glenn S. Warner

Corporate Officer/Principal

Jordan Dubow

Corporate Officer/Principal

Li Malmberg

Corporate Officer/Principal

Youssef Bennani

Corporate Officer/Principal

Derrell Porter

Sales & Marketing

Douglas Feltner

Corporate Officer/Principal

Denelle Waynick

General Counsel

Christopher Kurtz

Corporate Officer/Principal

James P. Sullivan

Corporate Officer/Principal

Gentry Lassiter

Public Communications Contact

Karl G. Trass

Corporate Officer/Principal

Barbara McGovern

Corporate Officer/Principal

Saeed Motahari

Corporate Officer/Principal

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	18
Vrouw	6

Waarvan leden van het uitvoerend comité

Man	6
Vrouw	1

Waarvan bestuurders

Man	9
Vrouw	4

Herzieningen

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Nee

Controverses sur les droits de l'Homme

Nee

Controverses Subventions fiscales

Nee

Conforme à la finance Islamique

Nee

AbbVie is gespecialiseerd in het onderzoek naar en de ontwikkeling van therapeutische medicijnen. De producten zijn bestemd voor de behandeling van reumatische artritis, psoriasis, de ziekte van Crohn, de schildklier, de ziekte Parkinson, HIV, complicaties bij mucoviscidose, een laag testosterongehalte en complicaties in combinatie met een chronische nierziekte. De geografische verdeling van de omzet is de volgende: Verenigde Staten (76,4%), Duitsland (2,6%), Japan (2%), Canada (1,9%), China (1,6%), Frankrijk (1,4%), Spanje (1%), Verenigd Koninkrijk (0,9%), Italië (0,9%), Brazilië (0,8%), Australië (0,8%) en andere (9,7%).

Werknemers

55.000

Sector

Farmaceutische producten

Agenda

15:45 - American Society of Hematology Meeting - Abstract No - 11119

Meer informatie over het bedrijf